Testing effectiveness (Phase 2)UnknownNCT06022289
What this trial is testing
Pemigatinib for FGF/FGFR Alterations Advanced Pan Solid Tumors
Who this might be right for
Solid TumorFGF Receptor Gene MutationFGF Amplification+2 more
Tianjin Medical University Second Hospital 20